Uremic Bleeding: Closing the Circle After 30 Years of Controversies?
Open Access
- 15 October 1999
- journal article
- review article
- Published by American Society of Hematology in Blood
- Vol. 94 (8), 2569-2574
- https://doi.org/10.1182/blood.v94.8.2569.420k13_2569_2574
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- Guanidino compound metabolism in rats subjected to 20% to 90% nephrectomyKidney International, 1995
- Identification of guanidino succinate as a putative endogenous source of the endothelium derived relaxing factorBiochemical and Biophysical Research Communications, 1992
- Influence of uremia and hemodialysis on circulating interleukin-1 and tumor necrosis factor αKidney International, 1990
- L-arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxationBiochemical and Biophysical Research Communications, 1988
- Conjugated Estrogens for the Management of Bleeding Associated with Renal FailureNew England Journal of Medicine, 1986
- TREATMENT OF URAEMIC BLEEDING WITH CONJUGATED OESTROGENThe Lancet, 1984
- Reduced Platelet Thromboxane Formation in Uremia. EVIDENCE FOR A FUNCTIONAL CYCLOOXYGENASE DEFECTJCI Insight, 1983
- The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholineNature, 1980
- Factor VIII--related protein on vascular intima of patients with chronic renal failure and prolonged bleeding times.BMJ, 1978
- The biosynthesis of guanidinosuccinic acid by perfused rat liver.JCI Insight, 1976